Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?

References

• Conaghan PG, Alten R, Deodhar A, Sullivan E, Blackburn S, Tian H, et al. Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study. RMD Open 2020;6:e001240.
   PubMed Web of Science ®Google Scholar
• Gudu T, Gossec L. Quality of life in psoriatic arthritis. Expert Rev Clin Immunol 2018;14:405–17.
   PubMed Web of Science ®Google Scholar
• Olofsson T, Söderling JK, Gülfe A, Kristensen LE, Wallman JK. Patient-reported outcomes more important than objective inflammatory markers for sick leave in biologics-treated rheumatoid arthritis patients. Arthritis Care Res 2018;70:1712–16.
   Web of Science ®Google Scholar
• Olofsson T, Petersson IF, Eriksson JK, Englund M, Simard JF, Nilsson JA, et al. Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort. Ann Rheum Dis 2014;73:845–53.
   PubMed Web of Science ®Google Scholar
• Rathbun AM, Harrold LR, Reed GW. Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms. Clin Rheumatol 2015;34:653–63.
   PubMed Web of Science ®Google Scholar
• Geenen R, Overman CL, Christensen R, Åsenlöf P, Capela S, Huisinga KL, et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018;77:797–807.
   PubMed Web of Science ®Google Scholar
• ten Klooster PM, Veehof MM, Taal E, van Riel PL, van de Laar MA. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Ann Rheum Dis 2007;66:1485–90.
   PubMedGoogle Scholar
• Puyraimond-Zemmour D, Etcheto A, Fautrel B, Balanescu A, de Wit M, Heiberg T, et al. Associations between five important domains of health and the patient acceptable symptom state in rheumatoid arthritis and psoriatic arthritis: a cross-sectional study of 977 patients. Arthritis Care Res 2017;69:1504–9.
   PubMed Web of Science ®Google Scholar
• Schaible HG, von Banchet GS, Boettger MK, Bräuer R, Gajda M, Richter F, et al. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci 2010;1193:60–9.
   PubMed Web of Science ®Google Scholar
• Mease PJ. Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment. Curr Opin Rheumatol 2017;29:304–10.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19–28.
   PubMed Web of Science ®Google Scholar
• Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int 2017;37:1527–39.
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152:S2–15.
   PubMed Web of Science ®Google Scholar
• Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol 2019;33:101423.
   PubMed Web of Science ®Google Scholar
• Højgaard P, Ellegaard K, Nielsen SM, Christensen R, Guldberg-Møller J, Ballegaard C, et al. Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: a prospective cohort study. Arthritis Care Res 2019;71:798–810.
   Web of Science ®Google Scholar
• Olofsson T, Wallman JK, Jöud A, Schelin MEC, Ernestam S, van Vollenhoven R, et al. Pain over 2 years after start of biological versus conventional combination treatment in early rheumatoid arthritis: results from the randomised controlled SWEFOT trial. Arthritis Care Res 2021;73:1312–21.
   Web of Science ®Google Scholar
• Lourdudoss C, Di Giuseppe D, Wolk A, Westerlind H, Klareskog L, Alfredsson L, et al. Dietary intake of polyunsaturated fatty acids and pain in spite of inflammatory control among methotrexate treated early rheumatoid arthritis patients. Arthritis Care Res 2018;70:205–12.
   Web of Science ®Google Scholar
• Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700–12.
   PubMed Web of Science ®Google Scholar
• Rifbjerg-Madsen S, Christensen AW, Christensen L, Hetland ML, Bliddal H, Kristensen LE. Pain and pain mechanisms in patients with inflammatory arthritis: a Danish nationwide cross-sectional DANBIO registry survey. PLoS One 2017;12:e0180014.
   PubMed Web of Science ®Google Scholar
• Geborek P, Crnkic M, Petersson IF, Saxne T. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden. Ann Rheum Dis 2002;61:793–8.
   PubMed Web of Science ®Google Scholar
• Wadström H, Eriksson JK, Neovius M, Askling J. How good is the coverage and how accurate are exposure data in the Swedish biologics register (ARTIS)? Scand J Rheumatol 2015;44:22–8.
   PubMed Web of Science ®Google Scholar
• Geborek P, Nitelius E, Noltorp S, Petri H, Jacobsson L, sLarsson L, et al. Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales. Ann Rheum Dis 2005;64:1805–7.
   PubMed Web of Science ®Google Scholar
• Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res 2012;64:1699–707.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Mease PJ, Healy P, Helliwell PS, Fitzgerald O, Cauli A, et al. Outcome measures in psoriatic arthritis. J Rheumatol 2007;34:1159–66.
   PubMed Web of Science ®Google Scholar
• Lampa J. Pain without inflammation in rheumatic diseases. Best Pract Res Clin Rheumatol 2019;33:31703790.
   Web of Science ®Google Scholar
• Di Carlo M, Muto P, Benfaremo D, Luchetti MM, Atzeni F, Salaffi F. The neuropathic pain features in psoriatic arthritis: a cross-sectional evaluation of prevalence and associated factors. J Rheumatol 2020;47:1198–203.
   PubMed Web of Science ®Google Scholar
• Marchesoni A, De Marco G, Merashli M, McKenna F, Tinazzi I, Marzo-Ortega H, et al. The problem in differentiation between psoriatic related polyenthesitis and fibromyalgia. Rheumatology 2018;57:32–40.
   PubMed Web of Science ®Google Scholar
• Altawil R, Saevarsdottir S, Wedrén S, Alfredsson L, Klareskog L, Lampa J. Remaining pain in early rheumatoid arthritis patients treated with methotrexate. Arthritis Care Res 2016;68:1061–8.
   PubMed Web of Science ®Google Scholar
• Lee YC, Cui J, Lu B, Iannaccone CK, Shadick NA, Weinblatt ME, et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther 2011;13:R83.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol 2007;34:1674–83.
   PubMed Web of Science ®Google Scholar
• Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther 2015;17:11.
   PubMed Web of Science ®Google Scholar
• Iannone F, Nivuori M, Fornaro M, Venerito V, Cacciapaglia F, Lopalco G. Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis. Rheumatology 2020;59:1599–606.
   PubMedGoogle Scholar
• Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, et al. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Ann Rheum Dis 2013;72:949–54.
   PubMed Web of Science ®Google Scholar
• Eberhard A, Bergman S, Mandl T, Olofsson T, Rydholm M, Jacobsson L, et al. Predictors of unacceptable pain and unacceptable pain with low inflammation in patients with rheumatoid arthritis over 5 years after diagnosis. Arthritis Res Ther 2021;23:16935.
   Web of Science ®Google Scholar
• McWilliams DF, Walsh DA. Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British Society for Rheumatology biologics register. BMC Musculoskelet Disord 2016;17:337.
   PubMed Web of Science ®Google Scholar
• Björk M, Gerdle B, Thyberg I, Peolsson M. Multivariate relationships between pain intensity and other aspects of health in rheumatoid arthritis–cross sectional and five year longitudinal analyses (the Swedish TIRA project). Disabil Rehabil 2008;30:1429–38
   PubMed Web of Science ®Google Scholar
• Lindström U, Di Giuseppe D, Delcoigne B, Glintborg B, Möller B, Ciurea A, et al. Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration. Ann Rheum Dis 2021;80:1410–18.
   PubMed Web of Science ®Google Scholar
• Behrens F, Cañete JD, Olivieri I, van Kuijk AW, McHugh N, Combe B. Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature. Rheumatology 2015;54:915–26.
   PubMed Web of Science ®Google Scholar
• Monden R, Rosmalen JGM, Wardenaar KJ, Creed F. Predictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study. Psychol Med 2020 Jun 17:1–9. doi:10.1017/S0033291720001774.
   Google Scholar
• Coates LC, van der Horst-Bruinsma IE, Lubrano E, Beaver S, Drane E, Ufuktepe B, et al. Sex-specific differences in patients with psoriatic arthritis: a systematic review. J Rheumatol 2023;50:488–96
   PubMed Web of Science ®Google Scholar
• Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C. Enthesitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 2018;48:35–43.
   PubMed Web of Science ®Google Scholar
• Kasiem FR, Luime JJ, Vis M, Kok MR, Wervers K, Gerards AH, et al. Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world dutch south west early psoriatic arthritis study. Scand J Rheumatol 2021;50:124–31.
   PubMed Web of Science ®Google Scholar
• Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmström G, Larsson PT. Psoriatic arthritis group of the society for rheumatology. The Swedish early psoriatic arthritis register– 2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol 2008;35:668–73.
   PubMed Web of Science ®Google Scholar
• Punzi L, Podswiadek M, Oliviero F, Lonigro A, Modesti V, Ramonda R, et al. Laboratory findings in psoriatic arthritis. Reumatismo 2007;59:52–5
   PubMedGoogle Scholar
• Schoels MM, Aletaha D, Alasti F, Smolen JF. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. J Rheumatol 2007;34:1159–66.
   PubMedGoogle Scholar
• Gossec L, McGonagle D, Korotaeva T, Lubrano E, de Miguel E, Østergaard M, et al. Minimal disease activity as a treatment target in psoriatic arthritis: a review of the literature. J Rheumatol 2018;45:6–13.
   PubMed Web of Science ®Google Scholar
• McWilliams DF, Zhang W, Mansell JS, Kiely PDW, Young A, Walsh DA. Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort study. Arthritis Care Res 2012;64:1505–13.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Häuser W, Hassett AL, Katz RS, Walitt BT. The development of fibromyalgia – I: Examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain 2011;152:291–9.
   PubMed Web of Science ®Google Scholar
• Dobkin PL, Liu A, Abrahamowicz M, Carrier N, de Brum-Fernandes AJ, Cossette P, et al. Predictors of pain for patients with early inflammatory polyarthritis. Arthritis Care Res 2013;65:992–9.
   Web of Science ®Google Scholar
• Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 2017;76:1906–10.
   PubMed Web of Science ®Google Scholar